Drs. Dharam Kumbhani, Ki Park, and Ajay Kirtane review the late-breaking clinical trials from Tuesday Oct. 24 at TCT 2023 including PARTNER 3 (0:45) and Evolut (4:36). The ACC is providing coverage of the lates-breaking clinical science being presented at TCT 2023 in San Francisco. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page (linked here) Follow the ACC on Social Media (linked here) and use the hashtag #TCT23 (https://twitter.com/hashtag/TCT23).  

 Subscribe to Eagle’s Eye View